|
Metric-Based Presentations
These online survey-based studies are ideal for learning what other companies are doing, how they measure what they do, what resources they devote to activities, what they find effective, and other insights. These are useful for doing a gap analysis.
 | Brand Management and Product Leadership |
| |
| Business Communications |
| |
| Business Operations |
| |
| Clinical Operations |
| |
| Competitive and Business Intelligence |
| |
| Customer Service |
| |
| GBC Conferences |
| |
| Human Resources |
| |
| Industry |
| |
| Internet |
| |
| Knowledge Management |
| |
| Market Access |
| |
| Market Research, Analytics and Forecasting |
| |
| Marketing Management |
| |
| Medical Affairs |
| |
| Memberships |
| |
| New Product Development |
| |
| Patient Focused Services |
| |
 | Product Launch |
| |
| Case Studies in Successful Re-Launch: Zithromax and Wellbutrin  
|
Non-members: Click here to sign-up for a complimentary tour of
"Case Studies in Successful Re-Launch: Zithromax and Wellbutrin"
Study Overview
Successfully re-launching a pharmaceutical product is a difficult feat... (ID 4776)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1365.61
| |
|  |
| Product Relaunch: Setting Strategy for Success
|
Non-members: Click here to sign-up for a complimentary tour of
"Product Relaunch: Setting Strategy for Success"
Study Overview
The need to re-launch a pharmaceutical product can happen for many reasons... (ID 4775)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1126.00
| |
| |
| Sales Force Enthusiasm: Garnering Support for Product Re-Launch
|
Non-members: Click here to sign-up for a complimentary tour of
"Sales Force Enthusiasm: Garnering Support for Product Re-Launch"
Study Overview
Garnering sales force support for a re-launched pharmaceutical product can be a Sisyphean effort... (ID 4774)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1382.00
| |
| |
| Product Re-Launch: Determining the Ideal Marketing Investment
|
Non-members: Click here to sign-up for a complimentary tour of
"Product Re-Launch: Determining the Ideal Marketing Investment"
Study Overview
When product managers endeavor to re-launch a pharmaceutical product, they face numerous obstacles in securing funding for a re-launch and in determining the ideal mix of activities... (ID 4773)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1132.00
| |
| |
| Product Re-Launch Success: Key Findings
|
Non-members: Click here to sign-up for a complimentary tour of
"Product Re-Launch Success: Key Findings"
Study Overview
Re-launching a pharmaceutical product is a marketing challenge that no brand executive wants to face, but many often do... (ID 4772)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $284.00
| |
| |
| Product Character & Position: Choosing Changes for New Growth
|
Non-members: Click here to sign-up for a complimentary tour of
"Product Character & Position: Choosing Changes for New Growth"
Study Overview
Most companies eventually must face the daunting task of re-launching a pharmaceutical product... (ID 4771)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1124.00
| |
| |
| | |
| Best Practices in Global Pharmaceutical Launches
 |
Discover how the world's leading pharmaceutical companies develop global launch strategies, manage launch teams, cultivate thought leader support, integrate marketing activities, and conduct a host of other critical launch activities... (ID SM-120)
Companies Profiled: Merck, Sanofi-aventis, Eli Lilly, GlaxoSmithKline, more ...
Price: $7000.00
| |
| |
| | |
| | |
| | |
| | |
| Launching Pharmaceutical Megabrands: Best Practices in Marketing Blockbusters
 |
The findings in this Best Practices Benchmarking® Report will enable pharmaceutical executives to understand the winning strategies, practices, team structures and investment patterns that distinguish successful new product development and marketing planning... (ID SM-124)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, Bristol-Myers Squibb, Amgen, more ...
Price: $7962.00
| |
| |
| | |
| Thought Leader Development for Global Pharmaceutical Launches
|
A pharmaceutical company’s relationship with key thought leaders is vital to the success of a new product because thought leaders communicate opinions and recommendations that are often the deciding factor in influencing a physician to prescribe a new drug... (ID 4569)
Companies Profiled: Sanofi-aventis, Merck, Eli Lilly, GlaxoSmithKline, more ...
Price: $768.95
| |
| |
| | |
| Global Marketing Launch Strategy & Structure 
|
In today’s crowded marketplace, pharmaceutical companies must develop a strategy that supports business objectives and forms an effective launch team for their product to achieve attention... (ID 4567)
Companies Profiled: Merck, Sanofi-aventis, Eli Lilly, GlaxoSmithKline, more ...
Price: $812.95
| |
| |
| Key Factors in Successful Global Pharmaceutical Launches
|
Integrated global marketing launch systems generate rapid sales uptake and help produce blockbuster products that realize their maximum economic potential in the global marketplace... (ID 4564)
Companies Profiled: Sanofi-aventis, Merck, Eli Lilly, GlaxoSmithKline, more ...
Price: $274.95
| |
| |
| | |
| Launching Megabrands: Process Maps 
|
The document consists of a 7 process maps highlighting the marketing best practices performed by leading pharmaceutical companies at various stages of the development process: Pre-Clinical, Phase I, Phase II, Phase III, Submission, and Launch... (ID 4107)
Companies Profiled: Pfizer, Sanofi-aventis, MErck, GlaxoSmithKline, more ...
Price: $839.95
| |
| |
| | |
| | |
| Thought Leader Relationships: Building the Business
 |
Build and manage thought leader relationships to drive successful launches characterized by rapid sales uptake, high market share, and extended product life cycles... (ID SM-129)
Companies Profiled: AstraZeneca, Sanofi-aventis, GlaxoSmithKline Merck, Pfizer, more ...
Price: $5438.00
| |
| |
| | |
| Quality, Compliance and Regulatory |
| |
| R and AS Conferences |
| |
| Sales and Marketing |
| |
| Sales Leadership |
| |
| Samples and Free Reports |
| |
| (Not Categorized) |
| |
|